The Learning Center

HCT Core Topics Connection Module: Conditioning Regimens Used in Hematopoietic Cell Transplantation

This module will identify the goals of administering a conditioning regimen prior to HCT, discuss the non-hematologic dose limiting toxicities of chemotherapy agents commonly utilized in conditioning regimens, differentiate between myeloablative, reduced-intensity, and non-myeloablative conditioning regimens, and select an appropriate conditioning regimen for a patient based on disease and patient specific factors.

Presented by:

Binni Kunvarjee, PharmD, BCOP; Memorial Sloan Kettering Cancer Center

Maggie Nelson, PharmD, BCOP; The University of Kansas Health System

Vinita Pai, PharmD, MS; The Ohio State University and Nationwide Children’s Hospital


Key:

Complete
Failed
Available
Locked
Module Recording
Open to view video.
Open to view video.
You must register to access.
Slides
Open to download resource.
Open to download resource.
You must register to access.
Module Quiz
10 Questions  |  4 attempts  |  8/10 points to pass
10 Questions  |  4 attempts  |  8/10 points to pass
You must register to access.
Evaluation
6 Questions
6 Questions
You must register to access.
Certificate of Completion
No credits available  |  Certificate available
No credits available  |  Certificate available
You must register to access.